There isn’t an official list of exactly five stages of menopause, but the transition does follow a clear progression that most sources break into five recognizable phases: premenopause, early perimenopause, late perimenopause, menopause itself, and postmenopause. The scientific staging system used by researchers actually identifies seven substages, but these five capture the meaningful shifts your body goes through. Most women experience menopause between ages 45 and 55, with the entire transition spanning several years before and after your final period.
Premenopause: The Baseline
Premenopause covers your entire reproductive life before any menopause-related changes begin. Your menstrual cycles are regular and predictable, and your hormone levels follow their normal monthly rhythm. This phase includes your peak reproductive years and extends into the late reproductive stage, when fertility starts to quietly decline even though your periods still arrive on schedule.
The first detectable change happens before you notice anything different about your cycle. Ovarian reserve (the number of eggs your ovaries have left) drops, and your body begins producing slightly more follicle-stimulating hormone (FSH) to compensate. This increased FSH initially keeps estrogen levels stable, so you feel no different. Some women in their late 30s or early 40s notice their cycles shortening by a day or two. That subtle shift can be the earliest sign that the transition is approaching, even though full perimenopause may still be years away.
Early Perimenopause: Cycles Start Shifting
Early perimenopause is when most women first realize something is changing. The hallmark is a persistent difference of seven days or more in the length of consecutive cycles. A cycle that used to be 28 days might come in at 24 one month and 33 the next. “Persistent” means this variability recurs within about 10 cycles of the first irregular one, not just a single off month caused by stress or illness.
Hormonally, FSH levels rise and become more variable, bouncing around from month to month rather than following the steady pattern of your reproductive years. Estrogen doesn’t simply drop during this phase. In fact, roughly 45% of women experience a temporary rise in estrogen before it eventually declines. That rise happens because elevated FSH stimulates follicles that were previously dormant, and those follicles can produce surges of estrogen that exceed what your body made during peak reproductive years. This explains why some perimenopausal symptoms feel intense and unpredictable rather than like a gradual fade.
Common symptoms during this stage include heavier or lighter periods, breast tenderness, worsening PMS, early sleep disruptions, and the first hot flashes. Not everyone gets every symptom, and the intensity varies widely. This phase typically begins in the mid-40s, though it can start earlier.
Late Perimenopause: Longer Gaps, Stronger Symptoms
Late perimenopause is defined by stretches of 60 days or more between periods. Your ovaries are ovulating less frequently, and some cycles are anovulatory, meaning no egg is released at all. Hormone levels swing dramatically: FSH sometimes reaches menopausal levels and other times drops back to the range typical of younger women, all within a few months. Estrogen fluctuations become extreme, with unpredictable highs followed by prolonged lows.
This is typically when symptoms peak. Hot flashes and night sweats become more frequent or more intense. Sleep disturbance is common and has been linked to worse cardiovascular health markers in midlife women. Depression also occurs more frequently during this phase, related both to hormonal volatility and to the disruptive effects of vasomotor symptoms like hot flashes. Body composition starts shifting noticeably: research from the Study of Women’s Health Across the Nation (SWAN) found that the rate of fat gain doubles starting about two years before the final menstrual period, while lean muscle mass declines. These changes are driven by the hormonal shift itself, not simply by aging.
Cardiovascular risk factors also accelerate during late perimenopause. Total cholesterol, LDL cholesterol, and a protein linked to arterial plaque all increase sharply in the year before through the year after the final period. Arterial stiffness increases by roughly 7.5% within one year of the final period, independent of other heart disease risk factors. These changes make late perimenopause and early postmenopause a critical window for paying attention to heart health.
Menopause: The 12-Month Mark
Menopause is a single point in time, not a phase you live through. It’s defined as 12 consecutive months without a menstrual period. You can only identify it looking backward, because there’s no way to know in advance that a given period will be your last. The diagnosis is made clinically based on age and symptoms. Blood tests aren’t routinely needed, though FSH levels above 30 mIU/mL and very low estrogen levels can confirm menopause in situations where it’s unclear, such as after a hysterectomy.
The average age of menopause falls between 45 and 55 worldwide. When menopause occurs before age 45, it’s considered early. Before age 40, it’s classified as primary ovarian insufficiency, a distinct condition that affects ovarian function while some follicles may still remain. Primary ovarian insufficiency differs from natural menopause because the ovaries haven’t fully exhausted their supply of eggs, which means occasional ovarian activity (and even rare pregnancies) can still occur.
Postmenopause: Stabilization and New Risks
Postmenopause begins the day after you reach the 12-month mark and lasts for the rest of your life. Researchers divide it into early and late phases because the body continues changing for several years before settling into a new hormonal baseline.
Early Postmenopause
The first one to two years after your final period involve the most rapid hormonal shifts. FSH climbs steeply and estrogen drops to consistently low levels. This hormonal recalibration takes an estimated three to six years to fully stabilize. During this window, many of the cardiovascular and metabolic changes that began in late perimenopause continue. Visceral fat (the deep abdominal fat surrounding organs) increases, and measures of arterial health like carotid artery thickness worsen at rates that exceed what aging alone would explain. Bone density loss also accelerates, as estrogen plays a key role in maintaining bone strength.
Hot flashes and night sweats often persist into early postmenopause, though they gradually decrease in frequency for most women. Some women continue experiencing vasomotor symptoms for a decade or longer.
Late Postmenopause
In late postmenopause, hormone levels have stabilized at their new baseline. FSH stays high, estrogen stays low, and further reproductive hormone changes are minimal. The body’s concerns shift from hormonal turbulence to the longer-term effects of living without estrogen’s protective influence. Bone loss continues at a slower but steady pace, increasing fracture risk. Cardiovascular disease risk continues to climb. Vaginal and urinary tract tissue can become thinner and drier over time due to sustained low estrogen, a change that doesn’t resolve on its own.
The transition from “menopause symptoms” to “aging with low estrogen” is gradual, not abrupt. Late postmenopause is when the cumulative effects of years without estrogen become most relevant to overall health.
Surgical Menopause Skips the Stages
If your ovaries are surgically removed, you don’t progress through the stages described above. Instead, you go from your current hormonal state to postmenopause immediately. Estrogen levels drop abruptly rather than tapering over years, which often makes symptoms more sudden and severe. Research suggests surgical menopause may also affect verbal memory in ways that natural menopause does not, likely because the brain doesn’t have time to gradually adapt to lower hormone levels. Women who undergo surgical menopause before the typical age of natural menopause face a longer lifetime exposure to low estrogen, which has implications for bone and cardiovascular health.